Document ID: chunk:federal_register_of_legislation:F2024L00439:clause:1_2
Version: federal_register_of_legislation:F2024L00439
Segment Type: clause
Provision Reference: sch 1 cl 2
Character Range: 2729–4455

2  Description of activity

     This quality assurance activity is operated by the Monash University School of Public Health and Preventive Medicine which tracks the performance of high-risk implantable breast devices and identifies long-term device safety issues for breast implants, tissue expanders and matrices used in reconstructive and cosmetic breast surgery.

     Data relating to implantation, revision or explantation of breast devices is collected from participating hospitals and surgeons.

     The overall aim is to improve the safety of breast devices for patients in the following ways:

                   Collection of population-level data regarding breast devices implanted, revised and explanted, to assist patients, surgeons and hospitals, should a device warning or recall by made by the Therapeutic Goods Administration (TGA).
                   Monitoring and reporting the long-term performance of breast devices to identify potential device safety issues, and providing performance information to the TGA, to assist it in its regulatory capacity.
                   Monitoring and reporting on potential trends and complications associated with breast device surgery.

     De-identified results are reported back to participating clinicians, health service providers and other key stakeholders on the long-term performance of breast implant devices to enhance long-term monitoring and improve patient safety.

     De-identified aggregated data is also published in:

                   Annual reports produced by the Australian Breast Device Registry
                   Academic publications in surgical journals
                   Quality and safety reports provided to device companies.